2.720USD-4.56%Mkt Cap: 69.09M $P/E: —2d ago
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap69.09M $
Enterprise Value52.58M $
Revenue (TTM)0 $
Gross Profit-13.15M $
Net Income (TTM)-19.18M $
Revenue/Share0.0000 USD
Last Price2.720 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees16
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.50
PEG—
EV/EBITDA-2.06
EV/Revenue—
P/SInfinity
P/B3.08
EPS (TTM)-1.87
EPS (Forward)-1.05
52W Range
1.22022% of range7.920
52W High7.920 USD
52W Low1.220 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE51843.24%
ROA-275.96%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.95M $
CapEx (TTM)59.00K $
FCF Margin—
FCF Yield-17.50%
Net Debt-19.82M $
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity-84.92
Current Ratio6.65
Quick Ratio6.12
Book Value/Sh0.8520 USD
Cash/Share0.9060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split28:1000
Split DateMar 15, 2024
Analyst Consensus
Rating—
Target (Mean)9.500 USD
Upside (mean)+249.3%
Target Range8.000 USD – 11.00 USD
$8.000+249.3% to mean$11.00
# Analysts2
Ownership
Shares Out.15.00M
Float—
Insiders50.75%
Institutions5.55%
Short Interest
Short Ratio5.7d
Short % Float1.94%
Short % Out.1.49%
Shares Short222.92K
Short (prev mo.)285.43K
Technical
SMA 502.109 (+28.9%)
SMA 2002.399 (+13.4%)
Beta—
S&P 52W Chg20.80%
Avg Vol (30d)52.50K
Avg Vol (10d)80.71K
Technical Indicators
RSI (14)66.7
MACD0.2110
MACD Signal0.1620
MACD Hist.+0.0490
BB Upper3.030 USD
BB Middle2.364 USD
BB Lower1.698 USD
BB Width56.32%
ATR (14)0.1924 USD
Vol Ratio (20d)2.99x